The groundbreaking treatment of tirzepatide peptide represents a significant advance in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide907248.daneblogger.com/40709677/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment